𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146–154 peptide

✍ Scribed by Supriya Perambakam; Sigrun Hallmeyer; Samarth Reddy; Nadim Mahmud; Linda Bressler; Phillip DeChristopher; Delores Mahmud; Rafael Nunez; Jeffrey A. Sosman; David J. Peace

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
391 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination of advanced prostate cancer
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
✍ Anna-K. Thomas-Kaskel; Robert Zeiser; Rosa Jochim; Christian Robbel; Wolfgang Sc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB

## Abstract Prostate stem cell antigen (PSCA) and prostate‐specific antigen (PSA) are overexpressed in most prostate cancers. PSCA‐ and PSA‐derived, HLA‐A2 binding peptides are specific targets for T‐cell responses __in vitro.__ A phase I/II trial was performed to demonstrate feasibility, safety an

Report of immune monitoring of prostate
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)
✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut